Global Competitiveness in the Pharmaceutical Industry: The Effect of National Regulatory, Economic, and Market Factors

Global Competitiveness in the Pharmaceutical Industry: The Effect of National Regulatory, Economic, and Market Factors

by Madhu Agrawal

Hardcover

$79.95

Overview

Examine the global pharmaceutical industry and the effect of national, regulatory, economic, and market environments on the competitiveness of the industry!

This unique book is the only empirical study that examines the effects of the national environment on the competitiveness of a country's pharmaceutical industry. This informative book explores such topics as the types of comparative advantages that firms use for developing competitive advantages and what strategic choices firms should make when collaborating with international firms. Public policy implications with respect to the economic environment are also discussed to give you a complete look at the international pharmaceutical industry.

Global Competitiveness in the Pharmaceutical Industry recognizes pharmaceutical industries as being of great social and public importance to all countries, since so many life saving drugs have emerged from pharmaceutical laboratories over the past four decades. By helping to combat many fatal diseases and eradicate others, drug producers have helped to positively alter mortality patterns in many parts of the world, thus making companies compete to provide many important medicines.

The unique research presented in this book examines the determinants of global competitive advantage in the pharmaceutical industry by answering such questions as:

  • Which factors stimulate or inhibit a nation's pharmaceutical industry to be globally innovative?
  • Which factors stimulate or inhibit diffusion of pharmaceutical innovations (NECs) into its markets?
  • Are there differences between industrialized and developing countries with respect to factors that affect innovation and global competitiveness in the pharmaceutical industry?

    Global Competitiveness in the Pharmaceutical Industry makes several theoretical, empirical, and methodological contributions which lead to results and generate important managerial and public policy implications. You will find a comprehensive overview of the nature of global competition in the pharmaceutical industry and its evolution in the post World War II period. Global Competitiveness in the Pharmaceutical Industry provides you with an in-depth understanding of the dynamics and importance of the global pharmaceutical market.

Product Details

ISBN-13: 9780789007155
Publisher: Taylor & Francis
Publication date: 01/28/1999
Pages: 188
Product dimensions: 5.90(w) x 8.60(h) x 0.90(d)

Table of Contents

Contents
  • List of Tables
  • Chapter One: the Global Pharmaceutical Industry
  • Present Status and Environment
  • Evolution of the Global Industry
  • Unique Characteristics of the Industry
  • Determinants of Competitiveness in the Global Pharmaceutical
  • Industry
  • Summary
  • Chapter Two: National Environment and Global Competitiveness
  • National Competitiveness - Theoretical and Conceptual Perspectives
  • Definition of National Competitiveness
  • Theory of Comparative Advantage
  • The Technology Factor Theory
  • The Role of Government and Public Policy
  • Competitiveness in the Global Pharmaceutical Industry
  • Role of Regulation, R&D and Innovation
  • Pharmaceutical Diffusion and Competitiveness
  • Supply and Demand Factors in Pharmaceutical
  • Competitiveness
  • Developing Country Competitiveness Issues
  • Global Strategic Perspectives
  • Core Competencies
  • Comparative Advantage-Based Competitive Advantage
  • Collaborate to Compete
  • Chapter Three: Methodology
  • Research Questions
  • Executive Survey
  • Model Development
  • The Global Innovation Model (GIM)
  • The Global Diffusion Model (GDM)
  • Constructs, Measures and Data Sources
  • Data Sources, Sample Size and Time Frame
  • Hypotheses
  • Statistical Method of Analysis - EQS
  • Uses of Structural Equation Modeling (SEM)
  • Steps in Structural Equation Modeling
  • Indirect Effects and Two-group Analysis
  • Chapter Four: Results
  • Global Innovation Model - Results
  • Effect of GNP, Price Regulation and Market Size on Innovation
  • Effect of GNP, Price Regulation and Industry Focus on Innovation
  • Effect of GNP, Price Regulation and Industry Growth on Innovation
  • Effect of GNP, Price Regulation and Industry Concentration on Innovation
  • Effect of Population, Approval Time and Market Size on Innovation
  • Effect of Population, Approval Time and Industry Focus on Innovation
  • Effect of Population, Approval Time and Industry Growth on Innovation
  • Effect of Population, Approval Time, Industry Concentration and Foreign Commitment on Innovation
  • Group Differences - Industrialized and Developing Countries
  • Significant Indirect Effects on Innovation and Global Competitiveness
  • Global Diffusion Model - Results
  • Conclusions
  • Chapter Five: Conclusions
  • Summary of Results
  • Determinants of Global Innovation
  • Global Innovation Factors for Industrialized versus Developing Country Industries
  • Implications of Study Results
  • Managerial Implications
  • Public Policy Implications
  • Contributions of Study
  • Theoretical Contributions
  • Empirical Contributions
  • Methodological Contributions
  • Managerial and Public Policy Contributions
  • Limitations of Study
  • The Environment for the Global Pharmaceutical Industry in the Future
  • List of References
  • Appendix A
  • Appendix B
  • Index
  • Reference Notes Included

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews